CC BY-NC-ND 4.0 · South Asian J Cancer 2015; 04(03): 134-139
DOI: 10.4103/2278-330X.173175
Review Article

Fertility preservation in young patients with cancer

Virender Suhag
Department of Radiation Oncology, HOD Radiation Oncology, Army Hospital (Research and Referral), New Delhi
,
B. S. Sunita
Department of Pathology, Base Hospital, New Delhi
,
Arti Sarin
Department of Radiation Oncology, HOD Radiation Oncology, Army Hospital (Research and Referral), New Delhi
,
A. K. Singh
Department of Radiation Oncology, HOD Radiation Oncology, Army Hospital (Research and Referral), New Delhi
,
Dashottar S.
Department of Radiation Oncology, HOD Radiation Oncology, Army Hospital (Research and Referral), New Delhi
› Author Affiliations
Source of Support: Nill.

Abstract

Infertility can arise as a consequence of treatment of oncological conditions. The parallel and continued improvement in both the management of oncology and fertility cases in recent times has brought to the forefront the potential for fertility preservation in patients being treated for cancer. Many survivors will maintain their reproductive potential after the successful completion of treatment for cancer. However total body irradiation, radiation to the gonads, and certain high dose chemotherapy regimens can place women at risk for acute ovarian failure or premature menopause and men at risk for temporary or permanent azoospermia. Providing information about risk of infertility and possible interventions to maintain reproductive potential are critical for the adolescent and young adult population at the time of diagnosis. There are established means of preserving fertility before cancer treatment; specifically, sperm cryopreservation for men and in vitro fertilization and embryo cryopreservation for women. Several innovative techniques are being actively investigated, including oocyte and ovarian follicle cryopreservation, ovarian tissue transplantation, and in vitro follicle maturation, which may expand the number of fertility preservation choices for young cancer patients. Fertility preservation may also require some modification of cancer therapy; thus, patients’ wishes regarding future fertility and available fertility preservation alternatives should be discussed before initiation of therapy.



Publication History

Article published online:
31 December 2020

© 2015. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Bleyer A, Viny A, Barr R Cancer in 15- to 29-year-olds by primary site Oncologist 2006;11:590-601.
  • 2 Arora RS, Alston RD, Eden TO, Moran A, Geraci M, O'Hara C, et al. Cancer at ages 15-29 years: The contrasting incidence in India and England Pediatr Blood Cancer 2012;58:55-60.
  • 3 Kalyani R, Das S, Kumar ML Pattern of cancer in adolescent and young adults – A ten year study in India Asian Pac J Cancer Prev 2010;11:655-9.
  • 4 Revel A, Revel-Vilk S Fertility preservation in young cancer patients J Hum Reprod Sci 2010;3:2-7.
  • 5 Ajala T, Rafi J, Larsen-Disney P, Howell R Fertility preservation for cancer patients: A review Obstet Gynecol Int 2010;2010:160386.
  • 6 Pavone ME, Hirshfeld-Cytron J, Lawson AK, Smith K, Kazer R, Klock S Fertility preservation outcomes may differ by cancer diagnosis J Hum Reprod Sci 2014;7:111-8.
  • 7 Redig AJ, Brannigan R, Stryker SJ, Woodruff TK, Jeruss JS Incorporating fertility preservation into the care of young oncology patients Cancer 2011;117:4-10.
  • 8 Gwede CK, Vadaparampil ST, Hoffe S, Quinn GP The role of radiation oncologists and discussion of fertility preservation in young cancer patients Pract Radiat Oncol 2012;2:242-7.
  • 9 Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 2006;24:2917-31.
  • 10 Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol 2013;31:2500-10.
  • 11 Lee SJ, ASCO Fertility Preservation Guidelines Committee Preservation of fertility in patients with cancer N Engl J Med 2009;360:2680-3.
  • 12 Wallace WH, Anderson RA, Irvine DS Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncol 2005;6:209-18.
  • 13 Levine J, Canada A, Stern CJ Fertility preservation in adolescents and young adults with cancer J Clin Oncol 2010;28:4831-41.
  • 14 Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, et al. Adolescent and young adult oncology Clinical practice guidelines in oncology J Natl Compr Canc Netw 2012;10:1112-50.
  • 15 Vadaparampil ST, Quinn GP Improving communication between oncologists and reproductive specialists to promote timely referral of patients with cancer J Oncol Pract 2013;9:300-2.
  • 16 Vadaparampil ST, Hutchins NM, Quinn GP Reproductive health in the adolescent and young adult cancer patient: An innovative training program for oncology nurses J Cancer Educ 2013;28:197-208.
  • 17 Murphy D, Orgel E, Termuhlen A, Shannon S, Warren K, Quinn GP Why Healthcare Providers Should Focus on the Fertility of AYA Cancer Survivors: It's Not Too Late! Front Oncol 2013;3:248.
  • 18 Chhabra S, Kutchi I Fertility preservation in gynecological cancers Clin Med Insights Reprod Health 2013;7:49-59.
  • 19 Agrawal S Late effects of cancer treatment in breast cancer survivors South Asian J Cancer 2014;3:112-5.
  • 20 Wallace WH, Thomson AB, Saran F, Kelsey TW Predicting age of ovarian failure after radiation to a field that includes the ovaries Int J Radiat Oncol Biol Phys 2005;62:738-44.
  • 21 Critchley HO, Wallace WH Impact of cancer treatment on uterine function J Natl Cancer Inst Monogr 2005;34:64-8.
  • 22 Liao L, Doyle J, Crouch NS, Creighton SM Dilation as treatment for vaginal agenesis and hypoplasia: A pilot exploration of benefits and barriers as perceived by patients J Obstet Gynaecol 2006;26:144-8.
  • 23 Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G Testicular function following chemo-radiotherapy Eur J Obstet Gynecol Reprod Biol 2004;113 Suppl 1:S2-6.
  • 24 Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD Gonadal function after cancer treatment in adult men Tidsskr Nor Laegeforen 2008;128:461-5.
  • 25 Speiser D, Mangler M, Köhler C, Hasenbein K, Hertel H, Chiantera V, et al. Fertility outcome after radical vaginal trachelectomy: A prospective study of 212 patients Int J Gynecol Cancer 2011;21:1635-9.
  • 26 Schneider A, Erdemoglu E, Chiantera V, Reed N, Morice P, Rodolakis A, et al. Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer Int J Gynecol Cancer 2012;22:659-66.
  • 27 Suprasert P, Srisomboon J, Charoenkwan K, Siriaree S, Cheewakriangkrai C, Kietpeerakool C, et al. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer J Obstet Gynaecol 2010;30:294-8.
  • 28 Beiner ME, Hauspy J, Rosen B, Murphy J, Laframboise S, Nofech-Mozes S, et al. Radical vaginal trachelectomy vs radical hysterectomy for small early stage cervical cancer: A matched case-control study Gynecol Oncol 2008;110:168-71.
  • 29 Gunderson CC, Fader AN, Carson KA, Bristow RE Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: A systematic review Gynecol Oncol 2012;125:477-82.
  • 30 Morice P, Denschlag D, Rodolakis A, Reed N, Schneider A, Kesic V, et al. Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors Int J Gynecol Cancer 2011;21:951-63.
  • 31 Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, et al. Adolescent and young adult oncology, version 22014 J Natl Compr Canc Netw 2014;12:21-32.
  • 32 Resetkova N, Hayashi M, Kolp LA, Christianson MS Fertility Preservation for Prepubertal Girls: Update and Current Challenges Curr Obstet Gynecol Rep 2013;2:218-25.
  • 33 Perri T, Ben-Baruch G, Davidson T, Beiner ME, Helpman L, Hogen L, et al. Use of titanium spiral tacks for long-term oophoropexy before pelvic irradiation Int J Gynecol Cancer 2014;24:1133-6.
  • 34 Barahmeh S, Al Masri M, Badran O, Masarweh M, El-Ghanem M, Jaradat I, et al. Ovarian transposition before pelvic irradiation: Indications and functional outcome J Obstet Gynaecol Res 2013;39:1533-7.
  • 35 Deepinder F, Agarwal A Technical and ethical challenges of fertility preservation in young cancer patients Reprod Biomed Online 2008;16:784-91.
  • 36 Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: A 12-year retrospective analysis Hum Reprod 2014;29:1931-40.
  • 37 Badawy A, Elnashar A, El-Ashry M, Shahat M Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study Fertil Steril 2009;91:694-7.
  • 38 Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B, et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma Final results of a phase II trial from the German Hodgkin Study Group Ann Oncol 2010;21:2052-60.
  • 39 Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: A systematic review and meta-analysis Fertil Steril 2011;95:906-14e1-4.
  • 40 Johnson RH, Kroon L Optimizing fertility preservation practices for adolescent and young adult cancer patients J Natl Compr Canc Netw 2013;11:71-7.
  • 41 Debono DJ, Kohnke JM, Helft PR Addressing Fertility in Patients With Advanced Cancer: How the Quality Oncology Practice Initiative Standards and ASCO Guidelines Facilitate Ethical Communication J Oncol Pract 2009;5:298-300.
  • 42 Trost LW, Brannigan RE Oncofertility and the male cancer patient Curr Treat Options Oncol 2012;13:146-60.
  • 43 Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: A national study of practice behaviors J Clin Oncol 2009;27:5952-7.
  • 44 Forman EJ, Anders CK, Behera MA A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients Fertil Steril 2010;94:1652-6.